Download PDF
Onkologische Welt 2020; 11(05): 222-224
DOI: 10.1055/a-1271-4410
Kongressnachlese

European Society for Blood and Marrow Transplantation

Wichtige Studienergebnisse von der virtuellen EBMT-Jahrestagung 2020
Ine Schmale∗
1   Westerburg
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Beim diesjährigen Jahreskongress der European Society for Blood and Marrow Transplantation (EBMT) wurden in der Plenarsitzung wichtige Studien zu neuen Therapieoptionen im Bereich nicht-maligner und maligner hämatologischer Entitäten präsentiert. Im Fokus stand auch die Forschung um die Graft-versus-Host-Disease (GvHD).



Publication History

Article published online:
04 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 de Latour RP. et al Results of the EBMT SAAWP phase III prospective randomized multicenter RACE study of horse ATG and ciclosporin with or without eltrombopag in naive SAA patients EBMT 2020 Abstract O018.
    Google Scholar
  • 2 Locatelli F. et al Superior event-free survival with blinatumomab versus chemotherapy in children with high-risk first relapse of B-cell precursor acute lymphoblastic leukemia: A randomized, controlled phase 3 trial EBMT 2020 Abstract O001.
    Google Scholar
  • 3 Zeiser R. et al Randomized phase 3 trial evaluating the efficacy and safety of ruxolitinib vs best available therapy in patients with steroid-refractory acute graft-vs-host disease (REACH2 trial) EBMT 2020 Abstract O081.
    Google Scholar
  • 4 Müller A. et al JUN activation in dermal fibroblasts promotes fibrosis and inflammation in sclerodermatous graft-vs-host disease in mice and humans EBMT 2020 Abstract O096.
    Google Scholar